Gold has corrected sharply from record highs as a stronger US dollar, elevated bond yields and expectations of prolonged higher interest ra...

Bitcoin's next rally is likely to be driven by liquidity, ETF inflows and monetary conditions rather than retail hype, according to Mudrex'...

Indian consumer goods giants Dabur and Godrej Consumer Products reported resilient demand in early fiscal 2027, defying geopolitical worrie...

Dabur India anticipates a significant boost in its first-quarter profit, driven by strategic price hikes that effectively countered rising ...

Indian auto sector anticipates strong demand across all vehicle types, though automakers may see profit margins squeezed in early FY27. Who...

A recent U.S. jobs report, showing slower-than-expected growth and downward revisions, has eased investor fears of persistent inflation and...

The Indian rupee reversed early gains on Thursday, succumbing to dollar demand from arbitrage trades as central bank intervention eased. Af...

The Federal Reserve is unlikely to alter interest rates soon, as inflation moderates and the economy remains stable, according to Steve Eng...

KPIT Technologies shares tumbled nearly 17% after issuing a weaker-than-expected outlook for FY27. European automakers, facing profitabilit...

Penalty shootouts, while thrilling, often see elite footballers falter under immense pressure. Research indicates that the weight of expect...

Oil prices declined as investors watched Iran-US talks, the recovery of shipping through the Strait of Hormuz, and upcoming US inventory da...

“India is also a protein-deficient market. We already have offerings such as high-protein atta, soya chunks and protein shakes, and we will...

India's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...

Celebrity trainer Siddhartha Singh, who trains Tamannaah Bhatia, warns that Ozempic's real challenge begins post-weight loss. He stresses t...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...